首页> 美国卫生研究院文献>Springer Open Choice >Monolith immuno-affinity enrichment liquid chromatography tandem mass spectrometry for quantitative protein analysis of recombinant bovine somatotropin in serum
【2h】

Monolith immuno-affinity enrichment liquid chromatography tandem mass spectrometry for quantitative protein analysis of recombinant bovine somatotropin in serum

机译:整体免疫亲和富集液相色谱串联质谱法测定血清中重组牛生长激素的蛋白质含量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The use of recombinant bovine somatotropin (rbST) to enhance milk production is approved in several countries, but it is prohibited in the European Union. According to EU legislation, it is necessary to confirm positive screening results prior to enforcement. Although adequate screening assays are available nowadays, development of liquid chromatography tandem mass spectrometry (LC-MS/MS) confirmatory methods to detect low levels of rbST is still a challenge. Here, we present a novel approach using immuno-affinity enrichment on monolithic micro-columns in combination with state-of-the-art ultra-high pressure LC-MS/MS (UHPLC-MS/MS) detection. The developed approach enables detection and confirmation of rbST in serum at a decision limit (CCα) concentration of 0.8 ng mL−1. Furthermore, the method is easy to handle, robust and reproducible. We successfully applied the confirmatory method to serum samples from rbST treated cows that were found suspect after immunoassay-based screening. The use of rbST could be confirmed over 1 week after treatment, and the developed method demonstrated the sensitivity needed for effective control.>Graphical AbstractGraphical summary of the workflow, for serum preparation, enrichment with monolith microcolumns and LC-MS/MS measurement of rbST
机译:多个国家已批准使用重组牛生长激素(rbST)来提高牛奶产量,但在欧盟中被禁止。根据欧盟法律,有必要在执行前确认阳性筛查结果。尽管如今有足够的筛查方法可用,但液相色谱串联质谱法(LC-MS / MS)的确证方法的发展仍然需要挑战,以检测低水平的rbST。在这里,我们提出了一种使用免疫亲和富集在整体微柱上结合最新技术的超高压LC-MS / MS(UHPLC-MS / MS)检测的新方法。所开发的方法能够以0.8 ngmL -1 的判定极限(CCα)浓度检测和确认血清中的rbST。此外,该方法易于操作,稳健且可重复。我们成功地将验证方法应用于rbST处理过的母牛的血清样品,这些样品在基于免疫测定的筛选后被发现可疑。可以在治疗后1周内确认使用rbST,并且开发出的方法证明了有效控制的敏感性。<!-fig ft0-> <!-fig @ position =“ anchor” mode = article f4- -> <!-fig mode =“ anchored” f5-> >图形摘要<!-fig / graphic | fig / alternatives / graphic mode =“ anchored” m1-> <!-标题a7- ->工作流程的图形摘要,用于血清制备,单块微柱富集和rbST的LC-MS / MS测量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号